e99 Online Shopping Mall
|
|
Help |
| Home - Health Conditions - Schizophrenia (Books) | |
|   | Back | 21-40 of 100 | Next 20 |
click price to see details click image to enlarge click link to go to the store
| 21. Schizophrenia: A Very Short Introduction (Very Short Introductions) by Christopher Frith, Eve Johnstone | |
![]() | Paperback: 216
Pages
(2003-09-25)
list price: US$9.95 -- used & new: US$5.36 (price subject to change: see help) Asin: 0192802216 Average Customer Review: Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description Customer Reviews (1)
Both authors appear to have strong academic credentials as well as extensive clinical experience with schizophrenia.(Christopher Frith is Professor of Neuropsychology at University College London and author of _The Cognitive Neuropsychology of Schizophrenia_ (1992).Eve C. Johnstone is Professor and Head of the Division of Psychiatry at the University of Edinburgh and author of _Schizophrenia: Concepts and Clinical Management_ (1999).)They look at schizophrenia both as a disease that afflicts individuals and as a public health issue, and cover the symptoms, causes and treatment of the illness. They discuss how the definition of the disease has evolved over time and continues to evolve as the priorities of the various symptoms change and the disease becomes better understood.They discuss both positive symptoms like delusions, hallucinations and disordered thought and negative symptoms like affective flattening and avolition.They pay special attention to auditory hallucinations ("voices") and delusions of control (imagined external control of body movements) and offer explanations of them based on improper working of feedback loops within the brain.They review different theories of the causes of schizophrenia and seem to give much more credence to physical (neurological) explanations (including heredity and circumstances of gestation and birth) than to psychogenic (purely "mental") ones (dysfunctional parents, double bind, etc.). Similarly they review different approaches to treatment and see much more significant results from antipsychotic drugs than from psychotherapy.In terms of the care of schizophrenia sufferers, they believe that the outcome for schizophrenia is generally poor (meaning that people who develop it generally do not fully recover from it), and I think they believe that suffers are generally better taken care of in institutional than in community settings. They claim that the common notion that schizophrenics have a strong propensity to violence is empirically not true but still recognize that there is a greater than average risk.I assume that their views are, over all, fairly standard, though probably not universal, within the medical and healthcare communities. I would say that the attitude of the authors towards the disease is not purely academic/clinical/managerial and but includes an element of genuine compassion for the sufferers as well as their families and care givers.I think the main hope that they hold out is that the neurological mechanisms underlying the disease will in time become well understood and that preventive and curative approaches based on those mechanisms will be developed. The contents of the book are: 1. The experience of schizophrenia References are essentially endnotes.There are no footnotes in the book. ... Read more | |
| 22. The Neuropathology of Schizophrenia: Progress and Interpretation | |
![]() | Hardcover: 374
Pages
(2000-10-15)
list price: US$95.00 -- used & new: US$78.30 (price subject to change: see help) Asin: 0192629077 Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description | |
| 23. Cognitive Remediation Therapyfor Schizophrenia: Theory and Practice by Til Wykes, Clare Reeder | |
![]() | Paperback: 315
Pages
(2005-09-22)
list price: US$34.95 -- used & new: US$29.13 (price subject to change: see help) Asin: 1583919716 Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description | |
| 24. Conquering Schizophrenia: A Father, His Son, and a Medical Breakthrough by Peter Wyden | |
![]() | Hardcover: 335
Pages
(1998-01-27)
list price: US$25.00 -- used & new: US$15.75 (price subject to change: see help) Asin: 0679446710 Average Customer Review: Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Amazon.com Jeff Wyden was a bubbly and vivacious child, described by his father as "unusually charming." In early adolescence, small changes occurred in Jeff's personality--his boundless energy was replaced with silence and a devastatingly low self-esteem. By age 21, Jeff had become severely psychotic and completely withdrawn from reality. So began the nightmare of schizophrenia. Jeff's story is eloquently told by his father, Peter Wyden. Although an inspirational book, especially for those affected by a mental illness, the Conquering Schizophrenia doesn't lapse into excessive sentimentality. Jeff is frequently portrayed as a monster, consumed by the wretched disease. Treatment options for the illness were particularly grim, including prefrontal lobotomies and electric-shock therapy. For more than two decades, Peter Wyden searched for a better answer, which eventually came with the development of new drugs. With this treatment, Jeff was "almost civilian" again. Wyden is an energetic and illuminating author who writes of a subject matter with which he has lived so closely for several decades. Customer Reviews (4)
What is the target?Is it Jeffhimself, who went from warm,extroverted child to introverted, erraticyouth, then back to a more normal, properly medicated 46-year old man? Isit mental illness itself?Which illness?Jeff's was diagnosed as"school phobia," "anxiety," "depression,""schizophrenia - paranoid type," then "malignant case ofmanic-depressive."Perhaps it is psychiatry itself, with its"foibles,follies, and failures," and its oddly noble persistancein the face of overwhelming enigmas? In any case, the target keepsmoving. This conveys Wyden's sense of confusion and hair-pullingfrustration through the dozens of psychiatrists, neuroleptics that ravagedthe body while they calmed the mind, the hospitals, and halfway houses thatmake up Jeff's existence.He shows us the "split" between modernmedicaters who treat the physical, and the traditional Freudians whobelieve only in the unconscious and psychoanalytic.He describes thebizarre events of pharmacology finds and the equally bizarre trip throughFDA approval.He narrates the bitter 20-year feud between Dr Spitzer andproponents of DSM series and the older therapists who call it a"straightjacket." The sound and fury, based on the void of theunknown, rages on.There is an abyss between etiologies, and chaos aboutcategories.Signs of schizophrenia dovetail so slyly into signs ofmanic-depression (hallucinations, hyperagitation) that even"experts" can't say which is primary. Medications for one crossover for the other."My learning curve was turning erratic,"complained Wyden when Clozaril came on the scene. ". . . Anythingmight work. Anything might fail. . . There are no true experts." Atthe book's end, Jeff is converting from Clozapin to the newer Olanzapine(the "breakthrough"), and seems to be emerging from hisdemi-world into a more responsive, organized person. His real diagnosis isstill up for grabs. The real breakthrough is hope, for today and fortomorrow, hope that research and medicine can cut through the profounddevastation of a broken brain. Wyden has painted a realistic picture ofmajor mental illness - ambiguous, unpredictable, messy, and bankrupting. Only those who have traveled that tunnel of despair can appreciate thecandle of this seemingly promising advance.
"Conquering Schizophrenia: A Father, His Son, and A Medical Breakthrough", published by Knopf, January 1998, is a father's account of the life of his son Jeff. Jeff's break came at age twenty-one. The book chronicles the next twenty-five years along two interwoven paths: the events in the lives of Jeff and his family and the evolution of the mental-health field during this time --its trends, controversies, therapies, medicines, practitioners, advocacy groups, agencies,economics, politics, etc. The father/author, Peter Wyden, has published a dozen books and was formerly a writer for Newsweek. He writes in a concise, organized, journalistic style that is mercifully free of any self aggrandizement that might have been expected (he candidly acknowledges his missteps) and of any excessive sentimentality (the story itself speaks eloquently of the emotions, frustrations, struggles and celebrations that were there throughout). He levels some very valid criticisms without being strident. It is carefully crafted with detailed back-of-the-book chapter notes, bibliography and index for the reader who wants to dig deeper. It is very up to date, mentioning situations as of Fall, 1997. (Of course we Internet devotees want to know how things are going this morning.) I strongly recommend this book highly to anyone whose life has been affected by schizophrenia or by any other serious mental illness. I have been struck over the last four years (our 23-year old son was diagnosed with schizophrenia four years ago) how much I read about one mental illness that relates to the others. (Incidentally, I have no connection to the publisher or author. I wish I did know the Wydens personally). Jeff was treated by over 50 docs over the 25-year period. He was "treated" in every imaginable theater from the renowned Menninger Clinic, where at the time of Jeff's stay early on, probably did more harm than good, to a run-down half- way house, where he was helped greatly by a dedicated, compassionate social worker. His symptoms when bad were very bad. He once broke a nurse's nose. He was not an easy patient and not an easy son. But those that got to know the real Jeff were very fond of him. And to his father, even after spending 25 years of struggling with Jeff over meds, docs, hygiene, etc., maybe to some extent because of those struggles, Jeff was a hero, a theme often repeated. Family support helped (and I suspect help greatly) throughout. There were some talk/cognitive therapies here and there that helped deal with some of the problems of the underlying illness. Jeff's manic periods were helped by lithium. There were other meds that I cannot recount. A breakthrough came with Clozapine, though negative symptoms, especially lack of motivation, remained and a purposeful day, much less the possibility of a job, were not on Jeff's radar screen and he spent his hours at the half-way house. The "conquering" word in the title refers to the next breakthrough which came with Olanzapine in 1996. Some of the negative symptoms begin to remit. The book ends with Jeff beginning to take some steps into the mainstream world and he gets involved with a local church program and one day asks his dad "Do you think you could get me a watch? I'd like to get my days organized". (!) You would have to read the whole story to understand what a wonderful ending (beginning) this is. Perhaps I wouldn't have divulged the ending if the book only dealt with Jeff's situation. It would have been a great book if limited to just the Jeff story. Many of us could identify and empathize and imagine our own books. Not to take away from the story, the real strength of this book for me was the second interwoven thread that dealt with the many aspects of the mental-health system as it evolved over the same twenty-five-year period and the interplay of that with Jeff's life. The author was relentless in his researching, advocating and mainly getting to know individuals who could help his son. He knew or got to know many of the movers and shakers, those at the tops of their fields, and gleaned from them a detailed and realistic survey of the battlefield on which his son found himself. I have spent a lot of time myself the last few years reading, surfing the Web, meeting, etc., but was left with a lot of questions and perhaps was left without a a good overall perspective of how the many pieces interact. The author does a masterful job of covering many areas and gleaning the salient features, good and bad, things you are never going to read in a journal or hear admitted for the record. For example, from a discussion with Dr. Solomon Snyder, the inventor of Prozac: "One question has run through Snyder's professional life: What exactly causes schizophrenia? ... 'We know solittle he said', he said sadly. 'There's a screw loose, but we don't know which screw.'" I think I would like to have known this four years ago rather than having to discover it over time. The book is filled with nuggets like this. The wide-ranging areas covered include: the slow, grudging acceptance of using meds for treatment, later the doctrinaire rejections by the biological guys of the talk therapy guys, (thank goodness my son's doc is dual-track), the fights over wording of the DSM-III, the history of anti-psychotic meds (amazing twists and turns), meds in the pipeline, the R. D. Laing school, orthomolecular treatment, psychosocial treatment, electro-convulsive therapy, schizophrenogenic mothers,"Toxic Psychology" book, "One Flew Over the Cuckoo's Nest" movie, Marilyn Monroe, atrocious experiments and abridgment of patient rights, sexual abuse, the history of the National Alliance of the Mentally Ill, the champions of mental health legislation in Washington, the big, profitable, competitive pharmacy business (Eli Lily sales of Olanzapine in 1997 about $850 million), the National Institute of Mental Health, various studies and meta studies (and the ongoing puzzlement), interviews with consumers, interviews with the big names, etc. He writes of many problems/challenges: the general stumbling nature of the progress in this field, the unknown causes of the illness, the problems of diagnosis and the diagnostic categories, questions about treatment, side- effect tradeoffs, stigma, managing the managers, family stresses, under funding of research and support agencies and the crushing work loads, poverty- producing expenses, bureaucracy, on and on. I found the book very satisfying in many ways. It most of all helps sustain our hope. And makes us appreciate the fact that despite all the difficulties we families are facing in 1998, times and prospects were much worse just a few years age. It chronicles a story we can relate to and can compare to our families' stories. It always held up the humanity, the personality of Jeff. It shines a light on the battlefield that still has its challenges and dangers but through which we can now walk with more confidence and with a better chance of survival or even conquest. I wish the best to the Wydens and to all the many families doing battle. ... Read more | |
| 25. Personal Therapy for Schizophrenia and Related Disorders: A Guide to Individualized Treatment by Gerard E. Hogarty | |
![]() | Hardcover: 332
Pages
(2002-08-15)
list price: US$42.00 -- used & new: US$37.97 (price subject to change: see help) Asin: 157230782X Average Customer Review: Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description Customer Reviews (2)
For over 30 years, Hogarty and his colleagues have developed a series of psychososcial interventions (major role therapy, family psychoeducation, social skills training, personal therapy , and, most recently, cognitive enhancement therapy) and submitted each to rigorous empirical trials.After each trial, he carefully examines the data and formulates new approaches which incorporate his prior research findings and empirical data from other sources. In the volume, Hogarty presents an approach to individual psychotherapy which he entitles "personal therapy" (PT).He describes his prior research efforts, most notably his two-year study of family psychoeducation which demonstrated a dramatic reduction in relapse in the first year of treatment, but a reduction in therapeutic efficacy as time passed. While observing that ameliorating family stressors reduced relapse, he also observed that family psychoeducation had no significant impact on the personal or social adjustment of schizophrenic patients. Based on these prior experiences, PT uses a three-phase approach, the first focusing on clinical and environmental stabilization, the second on symptom management, and the third on developing new social and vocational initiatives.Throughout all phases, all patients were maintained on antipsychotic medications which were carefully titrated to minimize side effects.The progression of patients through these phases was determined by each patient's rate of progress, not by a prearranged protocol.Until the goals of one phase were accomplished, the goals of the next phase were not initiated. The research protocol followed patients for three years, an unprecedented duration for any intervention study in schizophrenia. Before describing the three phases of PT, Hogarty devotes a chapter to outlining "essential prerequisites" for this intervention in considerable detail noting "that for decades are program has been guided by a silent mantra: innovative psychosocial treatment is for naught unless the fundamentals of good care are firmly in place (Hogarty's emphasis). His definition of "good care" includes psychological support (attentiveness, empathy, and encouragement), material support (financial support, stable housing, case management) and skillful medication management.Unique in the treatment literature, Hogarty addresses both the oft-ignored subject of obtaining government disability benefits and the intricacies of medication management.While the details of the former will be of little interest to most British readers, his attention to such seemingly mundane, yet essential, matters is impressive. (The clinic spent over $6000 annually for transportation subsidies when these costs were an impediment to clinic attendance.) With these prerequisites in place, the first "basic" phase of treatment is initiated as a therapeutic team continues medications, "joins" with the patient and family, and educates patients about their illness using a stress-vulnerability model.In the second "intermediate" phase, patients examine their own illness is greater detail, exploring the precipitants of relapse, and finally coping strategies for symptom management are taught.Finally, in the third "advanced" phase, patients maintain stability and apply these coping strategies as they undertake new social and vocational initiatives. Besides outlining the essential elements of PT, Hogarty describes the three-year controlled research protocol in considerable detail.In his discussion of the data, he carefully explores the considerable improvement of the control "supportive treatment" group, examining the therapeutic effects of "good care" and clinical management enjoyed by both experimental groups.However, while there was little significant difference between both treatment groups in both symptomatic presentation and functional adjustment at the one year mark (both groups improved significantly), the control group's progress leveled off while the PT group made impressive gains over the next two years. However, examining patters of relapse, Hogarty observed that a subgroup of PT patients who lived alone actually had a far higher rate of relapse than did patients who received "supportive treatment" only.He commented that "we wondered whether these historical negative effects of psychotherapy might have had less to do with the intervention per se and more with cognitively overwhelming life experiences" (p. 64).Not surprisingly, patients with strong family support had much better outcomes. This sort of multidimensional data analysis is perhaps unprecedented in the field of schizophrenia research, whether involving biological or psychosocial interventions.Hogarty sifts through his research data with a refreshing deftness and honesty; when the data does not support the efficacy of his intervention model, he straightforwardly acknowledges this and attempts to learn from negative as well as positive findings.In doing so, he briefly notes his most recent attempts to enhance the cognitive functioning of schizophrenic patients, an approach which is yielding impressive results. In spite of this impressive empirical data, many psychotherapists may reject Hogarty's embrace of biological psychiatry and his neglect of psychoanalytic conceptualizations.He has little patience with intriguing metaphors or sophisticated interpretations.Yet, among the impressive array of data, Hogarty writes with a passionate concern for the well-being of persons with schizophrenia that is so often overwhelmed by statistical analysis.Researchers of schizophrenia would do well to learn from his sophisticated, yet readable, analyses.At the same time, psychotherapists treating schizophrenic patients will emerge with a better appreciation of the interplay of the biological, psychological and environmental dimensions of this complex disorder. ... Read more | |
| 26. Schizophrenia: A Scientific Delusion? by Mary Boyle | |
![]() | Paperback: 352
Pages
(2002-04-05)
list price: US$31.95 -- used & new: US$40.51 (price subject to change: see help) Asin: 0415227186 Average Customer Review: Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description Customer Reviews (1)
| |
| 27. A User's Guide to Capitalism and Schizophrenia: Deviations from Deleuze and Guattari by Brian Massumi | |
![]() | Paperback: 235
Pages
(1992-03-06)
list price: US$22.00 -- used & new: US$13.71 (price subject to change: see help) Asin: 0262631431 Average Customer Review: Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description Customer Reviews (6)
It seems to me that this sort ofstrategy is symptomatic of a lot of works on both Deleuze and Deleuze'swork with Guattari.No one would deny that the works with Guattari andDeleuze's works "written in his own name" are exceedinglydifficult and require a lot of work to unlock, and that as a rule hiswritings in the history of philosophy are remarkably clear.As a result,there seems to be a refusal to read the independent works on their ownterms and a tendency to attempt to reduce them to the historical writings. While I would be the last to claim that the histories are to be ignored, itis nonetheless the case that the use of them ought to center arounddemonstrating how they converge with the independent works, how Deleuzerethinks their problematics, and where Deleuze diverges from them. Itis also likely that much of this textual practice comes from the latentimperative in Deleuze's philosophy to create.This has to do withDeleuze's textual strategy of "getting behind the author and creatinga monsterous offspring."As a result, those that write on Deleuzesimultaneously experience the necessity of merely doing commentary on whathe said in order to show how it belongs to a philosophical tradition andproblematic, while nonetheless being forced to remain silent on what hesaid.What seems to be forgotten are Deleuze's words immediately followinghis pronouncement of getting behind the author, where he claims that theonly rule is that the author himself must be shown to have said it. Moreover, much of the "creating" that goes on in the name ofDeleuze and Guattari comes to look like an arbitrary activity based on thewill of the author, rather than an expression of the impersonal andnecessary that D&G were always quick to emphasize.In other words,sometimes the greatest usefulness in writing about a text consists ingetting clear on what that text actually says in its own terms. Massumi'sbook can be highly illuminating and is a great and exciting read, but isnot necessarily the best source for coming to understand Deleuze andGuattari's difficult texts. One would do much better to first readsomething like Eugine Holland's book if their seeking to get an accuratepicture of what's going on in Deleuze and Guattari.
| |
| 28. Schizophrenia: A New Guide for Clinicians (Medical Psychiatry, Volume 16) | |
![]() | Hardcover: 352
Pages
(2002-01-11)
list price: US$149.95 -- used & new: US$39.00 (price subject to change: see help) Asin: 0824706420 Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description Contains guidelines and recommendations-in tabular form for quick reference-on patient evaluation and optimal treatment for long-term care!Based on evidence from recent systematic clinical research studies, this comprehensive reference provides the latest information on the assessment, diagnosis, and treatment of schizophrenia-highlighting modern diagnostic tools and current therapeutic advances for the prevention of hallucinations, thought disorganization, and negative symptoms.Emphasizes family education and psychoeducation, and community-centered treatments for patient rehabilitation and adherence to management programs!With consideration of the chronic nature of the disease, Schizophrenia details · the effect of substance abuse and drug dependence on rehabilitation and treatment · second-generation antipsychotic drugs, including olanzapine, quetiapine, risperiodone, and ziprasidone · contemporary strategies to prevent depression and suicide · patterns of patient compliance and noncompliance · violence and forensic hospitalization With over 600 useful references, Schizophrenia is an essential source for psychiatrists and psychopharmacologists, clinical neurologists and neuropsychopharmacologists, psychologists, primary care physicians, social workers, nurses, and graduate and medical school students in these disciplines. | |
| 29. Towards a Sociology of Schizophrenia: Humanistic Reflections by Keith Doubt | |
![]() | Paperback: 124
Pages
(1996-04-26)
list price: US$14.95 -- used & new: US$13.46 (price subject to change: see help) Asin: 0802078303 Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description Schizophrenia, at one time considered by many clinicians to be a psychological response to an oppressive upbringing, is now generally accepted as a physical illness. While Keith Doubt does not quarrel with this current view, he does challenge the positivist assumptions that tend to accompany it. Throughout this fascinating survey of the literature on schizophrenia, Doubt presents a critique of society's neglect of the mentally ill and promotes a humanistic understanding of the affected person as a social being. Doubt draws on several disciplines and uses the works of such diverse writers as Vygotsky, Piaget,Deleuze, Laing, and Torrey. While he rebukes medical practitioners for ignoring the social dimensions of schizophrenia, he is equally critical of post-modernism's tendency to valorize the mentally ill. Nor does he sympathize with particular sociological approaches which, he believes, emphasize society's reactions to the illness - often at the expense of the afflicted person. Thus, a major part of Doubt's project is to place the individual at the centre of sociological theorizing about schizophrenia. This thought-provoking study offers an alternative perspective on schizophrenia to scholars and professionals, as well as to those who live with the disease. Doubt offers practical recommendations, which he hopes will bring some relief to sufferers, and helpful insights to those engaged in treating or assisting people with schizophrenia. | |
| 30. Recovery from Schizophrenia: Psychiatry and Political Economy by Richard Warner | |
![]() | Paperback: 360
Pages
(2004-01-07)
list price: US$31.95 -- used & new: US$29.00 (price subject to change: see help) Asin: 0415212677 Average Customer Review: Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description Customer Reviews (1)
| |
| 31. Room For J: A Family Struggles With Schizophrenia by Daniel S Hanson | |
![]() | Paperback: 125
Pages
(2004-11-30)
list price: US$15.95 -- used & new: US$10.59 (price subject to change: see help) Asin: 1592980821 Average Customer Review: Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Product Description Customer Reviews (6)
| |
| 32. Healing Schizophrenia: Complementary Vitamin & Drug Treatments by Abram Hoffer | |
![]() | Paperback: 224
Pages
(2004-07)
list price: US$17.95 -- used & new: US$11.12 (price subject to change: see help) Asin: 1897025084 Average Customer Review: Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description Customer Reviews (7)
| |
| 33. Schizophrenia Defeated by James Stacey | |
![]() | Paperback: 154
Pages
(2004-05-29)
list price: US$8.95 -- used & new: US$8.95 (price subject to change: see help) Asin: 0954357345 Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Product Description | |
| 34. Essays in Schizophrenia by Bernard H. Shulman | |
| Paperback: 195
Pages
(1984-11)
list price: US$14.95 Isbn: 0918560292 Canada | United Kingdom | Germany | France | Japan | |
| 35. Understanding and Treating Cognition in Schizophrenia: A Clinician's Handbook by Philip D. Harvey, Tonmoy Sharma | |
![]() | Paperback: 192
Pages
(2002-01-31)
list price: US$59.95 -- used & new: US$48.40 (price subject to change: see help) Asin: 1841841331 Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description This handbook describes the most up-to-date knowledge on cognition in schizophrenia. Cognition is perhaps the most critical aspect of the disorder, and, for the first time, the authors assess all its features as well as the clinical implications of these deficits in the patient's everyday life. New medications enhance cognition without influencing the psychotic symptoms of the illness, and the most recent data on those effects are included, as is a unique review of cognition and aging. The book gives a concise but sophisticated analysis of cognitive deficits, their implications and developing treatment strategies. Any clinician working with schizophrenic patients will find this text essential. | |
| 36. Contemporary Diagnosis and Management of the Patient with Schizophrenia by Henry A. Nasrallah, Donald J. Smeltzer | |
![]() | Paperback: 248
Pages
(2003-01-01)
list price: US$19.95 -- used & new: US$1.00 (price subject to change: see help) Asin: 1931981027 Average Customer Review: Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description Customer Reviews (1)
| |
| 37. Family Work With Psychosis: Towards a Common Goal (International Society for the Psychological Treatment of Schizophrenia and Other Psychoses) by Bloch Thorsen | |
![]() | Paperback: 130
Pages
(2006-10-30)
list price: US$33.95 -- used & new: US$24.36 (price subject to change: see help) Asin: 1583917276 Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description | |
| 38. Natural Healing for Schizophrenia & Other Common Mental Disorders by Eva Edelman | |
| Paperback: 238
Pages
(1996-06)
list price: US$24.95 Isbn: 0965097668 Average Customer Review: Canada | United Kingdom | Germany | France | Japan | |
Customer Reviews (3)
| |
| 39. Schizophrenia: Straight Talk for Family and Friends by Maryellen Walsh | |
| Paperback:
Pages
(1993-08)
list price: US$10.00 Isbn: 0688125808 Average Customer Review: Canada | United Kingdom | Germany | France | Japan | |
Customer Reviews (3)
Of all the books I've read on this subject (and there are many), this is by far the most descriptive and in-depth informative book in this genre. Covering everything from stigma, to the effects of schizophrenia on a home/family, to causes, myths, and misconceptions and much more, this book will help you understand how to deal with the situation and move on to a more fulfilling life. Housing, work, social life, money, medication, heredity, and state involuntary committment laws, all paint a thorough picture on this sad and difficult state. Easy to read, thorough, honest, and well worth the small price, this book comes highly recommended. :v)
| |
| 40. Fantasy, Fact and Logic: Schizophrenia and Mysticism by A.T. CHUA | |
![]() | Paperback: 372
Pages
(2007-01-18)
list price: US$17.99 -- used & new: US$11.51 (price subject to change: see help) Asin: 1425977855 Canada | United Kingdom | Germany | France | Japan |
|
Editorial Review Book Description | |
|   | Back | 21-40 of 100 | Next 20 |